Biotech Clinical Trials in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Biotech Clinical Trials in Brazil

Biotech Clinical Trials in Brazil – Cohortias the CRO of LATAM

Biotech clinical trials have become vital for the development and evaluation of innovative therapies and treatments. Brazil, the largest country in South America, has emerged as a prominent player in the biotech industry and has witnessed significant growth in clinical trials. This article explores the advancements, potential, and regulatory landscape of biotech clinical trials in Brazil.

Growth of Biotech Clinical Trials in Brazil

Brazil has experienced substantial growth in biotech clinical trials, attracting both national and international researchers. The country boasts a large and diverse patient population, world-class research institutions, and a robust scientific community.

The increasing investment in healthcare infrastructure, research and development, and the presence of leading biotech companies have contributed to the expansion of clinical trials in Brazil.

Regulatory Framework

Brazil’s regulatory agency, the National Health Surveillance Agency (ANVISA), oversees the approval and regulation of clinical trials. ANVISA has implemented comprehensive regulations and streamlined processes to ensure patient safety and data integrity. The agency works in alignment with international standards, making Brazil an attractive destination for biotech clinical trials.

Collaboration with International Partners

Brazil actively engages in collaborations with international partners, including pharmaceutical companies, academic institutions, and contract research organizations (CROs). These partnerships facilitate knowledge exchange, technology transfer, and access to global expertise. Collaborative efforts have led to successful completion of numerous biotech clinical trials in Brazil.

Therapeutic Areas and Innovation

Biotech clinical trials in Brazil cover a wide range of therapeutic areas, including oncology, infectious diseases, neurology, cardiovascular diseases, and genetic disorders.

The country’s research institutions and hospitals have contributed to groundbreaking discoveries and the development of novel biotech therapies. Brazil’s rich biodiversity also provides opportunities for the exploration of natural products with therapeutic potential.

Biotech Clinical Trials in Brazil

Biotech Clinical Trials in Brazil

Biotech Clinical Trials in Brazil

Patient Recruitment and Diversity

Brazil’s diverse population offers a significant advantage for patient recruitment in clinical trials. The inclusion of diverse ethnic groups and genetic backgrounds allows for a better understanding of the impact of biotech products on different populations. This inclusivity ensures that innovative treatments and therapies are accessible to all segments of the population.

Infrastructure and Research Facilities

Brazil has made significant investments in healthcare infrastructure, establishing world-class research facilities and clinical trial sites. The country’s research centers are equipped with state-of-the-art technologies and employ highly skilled researchers. The availability of advanced infrastructure contributes to efficient trial execution and attracts researchers from around the world.

Challenges and Mitigation

While Brazil has made substantial progress, challenges exist in conducting biotech clinical trials. Limited funding, bureaucratic processes, and logistics can pose obstacles for researchers.

However, concerted efforts are being made by the Brazilian government, academia, and industry stakeholders to address these challenges. Initiatives focused on increasing funding, streamlining processes, and improving logistical support are being implemented to overcome these hurdles.

Ethical Considerations and Patient Protection

Ethics committees and Institutional Review Boards (IRBs) in Brazil play a critical role in ensuring patient protection and ethical conduct of clinical trials. These bodies evaluate study protocols, informed consent procedures, and monitor trial progress. Stringent adherence to ethical guidelines and international standards safeguards the rights and well-being of trial participants.

Future Prospects

The future of biotech clinical trials in Brazil holds immense potential. The government’s commitment to advancing the healthcare sector, coupled with increased investment in research and development, creates a favorable environment for biotech advancements.

The incorporation of emerging technologies, such as precision medicine, gene therapy, and immunotherapy, presents exciting opportunities for furthering biotech research in Brazil.


Brazil has emerged as a prominent destination for biotech clinical trials, showcasing advancements, potential, and a supportive regulatory landscape.

The country’s large and diverse patient population combined with its world-class research institutions and collaborative partnerships, positions Brazil as a key player in the field of biotech research. With a robust regulatory framework, advanced infrastructure, and a commitment to ethical conduct, Brazil offers an ideal environment for conducting biotech clinical trials.

Biotech Clinical Trials in Brazil

Source: Duke Clinical Research Institute

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Biotech Clinical Trials in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Biotech Clinical Trials in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Biotech Clinical Trials in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Biotech Clinical Trials in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Biotech Clinical Trials in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Biotech Clinical Trials in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Biotech Clinical Trials in Brazil

The Cohortias Team

Biotech Clinical Trials in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Biotech Clinical Trials in Brazil

Network & Partnerships